SPRO - Spero Therapeutics Inc. (SPRO) Q4 2023 Earnings Call Transcript
2024-03-13 17:45:09 ET
Spero Therapeutics, Inc. (SPRO)
Q4 2023 Earnings Conference Call
March 13, 2024, 04:30 PM ET
Company Participants
Michael Wood - Managing Director of LifeSci Advisors
Sath Shukla - CEO
Kamal Hamed - CMO
Esther Rajavelu - CFO and Chief Business Officer
Conference Call Participants
Ritu Baral - TD Cowen
Louise Chen - Cantor
Presentation
Operator
Good afternoon and welcome to the Spero Therapeutics Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following the company's formal remarks, we will open the call for questions. Please be advised that this call is being recorded and a replay will be available. You can find information on the replay and further information related to today's announcements on the Spero Therapeutics website at sperotherapeutics.com.
At this time, I would like to turn the call over to Michael Wood, Managing Director of LifeSci Advisors. Mr. Wood, please go ahead.
Michael Wood
Thank you, operator, and thank you all for participating in today's conference call. This afternoon, Spero Therapeutics released financial results and provided a business update for the fourth quarter and full year 2023. Our press release is available on the Investor page of the Spero Therapeutics website....
Spero Therapeutics, Inc. (SPRO) Q4 2023 Earnings Call Transcript